Evidence map›Paper›PMID 23287883›Full record

ArticleThe oncologist2013

"Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Jan Schildmann, Jacinta Tan, Sabine Salloch, Jochen Vollmann

Open access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tough Clinical Decisions: Experiences of Polish Physicians.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2024
    Article
  9. Perceptions of Fertility Physicians Treating Women Undergoing IVF Using an Egg Donation.International journal of environmental research and public health · 2022
    Article
  10. Article
  11. Article
  12. Chemotherapy Use at the End of Life in Uganda.Journal of global oncology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Multicriteria decision analysis in oncology.Health expectations : an international journal of public participation in health care and health policy · 2015
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jan SchildmannInstitute for Medical Ethics and History of Medicine, Ruhr-Universitaet Bochum, Malakowturm-Markstraße 258a, D-44799 Bochum, Germany. jan.schildmann@rub.de
Jacinta Tan
Sabine Salloch
Jochen Vollmann
Ruhr University Bochum · DESwansea University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurveys indicate considerable variation regarding the provision of cancer treatment at the end of life. The variation cannot be fully explained by differences concerning the clinical situation or patients' preferences. The aim of this qualitative study was to explore medical oncologists' experiences with advanced cancer, as well as their views of the relevance of medical and nonmedical criteria for decisions about limiting treatment.

methodsQualitative in-depth interviews were conducted with physicians working in medical oncology in tertiary care hospitals or district general hospitals in England. Purposive sampling and qualitative analysis were performed.

resultsPhysicians reported that a number of nonmedical factors influence professional decisions about the offering or limiting of cancer treatment in advanced cancer in addition to medical criteria. Physicians' individual judgments about the benefit of treatment, as well as the amount of their clinical experience, were cited as such factors. In addition, the physicians' perceptions of the patient's age and life circumstances were reported to influence their treatment decisions. Multiprofessional team discussions and the systematic collection of relevant clinical data regarding the outcomes of different treatment approaches in advanced cancer were suggested as strategies to improve the quality of treatment decisions.

conclusionThe findings of this study provide explanations for the variation in treatment in advanced cancer. Making value judgments explicit and gathering more appropriate clinical data on the outcomes of treatment near the end of life are prerequisites for improved ethical and evidence-based treatment decisions in advanced cancer.

Indexed as

AgedAttitude of Health PersonnelData CollectionDecision MakingEnglandFemaleHumansMaleMedical OncologyMiddle AgedNeoplasmsNeoplasm StagingPatient PreferencePhysician-Patient Relations

Identifiers

PMID23287883
PMCPMC3556262
OpenAlexW2156633254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.